Taysha Gene Therapies Stock (NASDAQ: TSHA) stock price, news, charts, stock research, profile.
Open | $2.20 |
Close | $2.15 |
Volume / Avg. | 5.46M / 2.20M |
Day Range | $2.13 - $2.20 |
52 Wk Range | 1.27 - 4.32 |
Market Cap | $436.59M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 13.94% |
Days to Cover | 24.68 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Taysha Gene Therapies (NASDAQ:TSHA) through any online brokerage.
Other companies in Taysha Gene Therapies’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Inozyme Pharma (NASDAQ:INZY), Korro Bio (NASDAQ:KRRO) and Larimar Therapeutics (NASDAQ:LRMR).
There is no analysis for Taysha Gene Therapies to provide a consensus price target.
The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $2.1303 last updated September 20, 2024 at 7:33 PM EDT.
There are no upcoming dividends for Taysha Gene Therapies.
Taysha Gene Therapies does not have any upcoming earnings scheduled.
There is no upcoming split for Taysha Gene Therapies.
Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.